...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New Zenith Drug ZEN-3365 Publication

Thanks for posting Bear.

I'm not a scientist but from reading the abstract it looks like Zenith could have another compound with promise.

Good news. Now we need biotech business strategists to move to value creation.

Toinv

Share
New Message
Please login to post a reply